Proteomic Analysis Reveals Upregulation of ACE2 (Angiotensin-Converting Enzyme 2), the Putative SARS-CoV-2 Receptor in Pressure-but Not Volume-Overloaded Human Hearts

Hypertension. 2020 Dec;76(6):e41-e43. doi: 10.1161/HYPERTENSIONAHA.120.16261. Epub 2020 Sep 24.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Angiotensin-Converting Enzyme 2
  • Area Under Curve
  • COVID-19
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / genetics*
  • Case-Control Studies
  • Comorbidity
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / epidemiology*
  • Female
  • Germany
  • Humans
  • Incidence
  • Logistic Models
  • Male
  • Mitral Valve Insufficiency / epidemiology*
  • Mitral Valve Insufficiency / genetics
  • Pandemics
  • Peptidyl-Dipeptidase A / genetics*
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / epidemiology*
  • Proteomics / methods
  • RNA, Messenger / analysis
  • Risk Assessment
  • Severe Acute Respiratory Syndrome / diagnosis
  • Severe Acute Respiratory Syndrome / epidemiology
  • Severe Acute Respiratory Syndrome / genetics*
  • Survival Analysis
  • Transcriptional Activation / genetics*
  • Up-Regulation / genetics

Substances

  • RNA, Messenger
  • Peptidyl-Dipeptidase A
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2